Clinical Trials Claeys

Oud-Heverlee ·KBO/BCE: BE 0863.913.573

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	25-08-2026	25 d late	2026-00433673
31-12-2024	31-07-2025	30-06-2025	31 d early	2025-00196120
31-12-2023	31-07-2024	20-06-2024	41 d early	2024-00155097
31-12-2022	31-07-2023	05-07-2023	26 d early	2023-00207380
31-12-2021	31-07-2022	21-07-2022	10 d early	2022-20209588
31-12-2020	31-07-2021	23-08-2021	23 d late	2021-53500347
31-12-2019	31-07-2020	26-08-2020	26 d late	2020-45300472
31-12-2018	31-07-2019	30-09-2019	61 d late	2019-67500014
31-12-2017	31-07-2018	25-06-2018	36 d early	2018-22500089
31-12-2016	31-07-2017	25-08-2017	25 d late	2017-47700561

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€872k
Fixed assets	21/28	€8k
Tangible fixed assets	22/27	€8k
Financial fixed assets	28	€700
Current assets	29/58	€864k
Amounts receivable within one year	40/41	€62k
Investments	50/53	€564k
Cash & bank	54/58	€238k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€872k
Equity	10/15	€757k
Contributions / capital	10/11	€19k
Reserves	13	€739k
Amounts payable	17/49	€115k
Amounts payable within one year	42/48	€115k
Trade debts payable within one year	44	€588
Income statement
Gross operating margin	9900	€247k
Operating result	9901	€245k
Financial income	75	€15k
Financial charges	65	€237
Result before taxes	9903	€260k
Income taxes	67/77	€84k
Net result for the period	9904	€176k
Result to be appropriated	9905	€176k

NACE primary	Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied(72109)
Legal form	Private limited company(610)
Incorporation	09-03-2004
Status	Active
Postal code	3052

Summary

Parcel (capakey)	Region	Area	Buildings	Height / fl.
24040A0155/00D002	Flanders	4,213 m²	1 · 186 m²	7.9 m · 1 fl.
24013A0128/00M002	Flanders	2,275 m²	1 · 213 m²	10.5 m · 2 fl.
24514A0145/00K003	Flanders	311 m²	1 · 89 m²	12.7 m · 3 fl.